MegRyan
08-11-2008, 10:48 AM
http://www.diamyd.com/docs/PressClip.aspx?PageID=4&ClipID=450
This is now also planned to work for Type 1, ongoing Phase III.
"This is the first time that it is shown in man, that an autoimmune disease can be neutralized long term by the same autoantigen that drives the disease", says Professor Åke Lernmark, University of Lund, co-investigator in the study.
"The fact that the Diamyd® vaccine shows significant positive long term effect in LADA patients is a first step towards prevention of autoimmune diabetes", says Elisabeth Lindner, President and CEO of Diamyd Medical. "We have now fully positioned our vaccine into two separate products; one for type1diabetes and a separate product for LADA. This is a large step towards building a pharmaceutical company within diabetes".
This is now also planned to work for Type 1, ongoing Phase III.
"This is the first time that it is shown in man, that an autoimmune disease can be neutralized long term by the same autoantigen that drives the disease", says Professor Åke Lernmark, University of Lund, co-investigator in the study.
"The fact that the Diamyd® vaccine shows significant positive long term effect in LADA patients is a first step towards prevention of autoimmune diabetes", says Elisabeth Lindner, President and CEO of Diamyd Medical. "We have now fully positioned our vaccine into two separate products; one for type1diabetes and a separate product for LADA. This is a large step towards building a pharmaceutical company within diabetes".